Potentials of ribosomopathy gene as pharmaceutical targets for cancer treatment
Abstract Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the…
Abstract Ribosomopathies encompass a spectrum of disorders arising from impaired ribosome biogenesis and reduced functionality. Mutation or dysexpression of the…
Abstract Despite growing evidence suggesting the critical function of NOL7 in cancer initiation and development, a systematic pancancer analysis of…